FDA Oncology medical reviewers wrote more than 500 articles for peer-reviewed journals from 2018-2023

FDA Oncology medical reviewers wrote more than 500 articles for peer-reviewed journals from 2018-2023

FDA Oncology posted on X:

“DYK? FDA Oncology medical reviewers wrote more than 500 articles for peer-reviewed journals from 2018-2023—articles about regulatory issues, drug approval summaries, and scientific analyses of clinical trial data.”

Read further.
Source: FDA Oncology/X

cancer treatment Clinical Trial Data Drug Approval DYK FDA FDA Insights FDA Oncology healthcare Medical Research Medical Reviewers OncoDaily Oncology Peer Reviewed Journals Regulatory Issues Scientific Analyses